https://data.archives-ouvertes.fr/author/179791

https://data.archives-ouvertes.fr/author/179791

http://xmlns.com/foaf/0.1/topic_interest CPP-functionalized particles
http://xmlns.com/foaf/0.1/topic_interest Nanoparticle therapeutic efficacy
http://xmlns.com/foaf/0.1/topic_interest Huntington disease
http://xmlns.com/foaf/0.1/topic_interest Amphiphilic nanoparticles
http://xmlns.com/foaf/0.1/topic_interest In vivo and in vitro models
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/chim.ther
http://xmlns.com/foaf/0.1/topic_interest Self-assembled nanoparticles
http://www.w3.org/2002/07/owl#sameAs 189618086
http://xmlns.com/foaf/0.1/name Angelina Angelova
http://www.w3.org/2002/07/owl#sameAs T-6403-2017
http://xmlns.com/foaf/0.1/topic_interest Brain-derived neurotrophic factor BDNF
http://xmlns.com/foaf/0.1/topic_interest Endoplasmic reticulum stress
http://xmlns.com/foaf/0.1/topic_interest Lipid nanoparticles liquid crystalline nanocarriers cubosomes cell-penetrating peptide CPP CPP-functionalized particles pituitary adenylate cyclase-activating polypeptide PACAP neuroprotection nanomedicine
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.sp.med
http://www.w3.org/2002/07/owl#sameAs http://www.researcherid.com/rid/T-6403-2017
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.can
http://xmlns.com/foaf/0.1/topic_interest Ginkgo biloba bioactive compounds
http://xmlns.com/foaf/0.1/topic_interest SHSY-5Y cells
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.sp.pg
http://xmlns.com/foaf/0.1/mbox_sha1sum 5eeb4ff60ccc43db3bff471037dc5042
http://xmlns.com/foaf/0.1/topic_interest Nanomedicine
http://xmlns.com/foaf/0.1/topic_interest Antioxidant-delivery nanosystems
http://xmlns.com/foaf/0.1/topic_interest Antioxidant
http://xmlns.com/foaf/0.1/topic_interest Pituitary adenylate cyclase-activating polypeptide PACAP
http://xmlns.com/foaf/0.1/topic_interest Antioxidant-delivery nanosystems lipid nanocarriers oxidative stress ROS neuroinflammation neurodegeneration neurological long COVID-19
http://xmlns.com/foaf/0.1/topic_interest Cubosomes
http://xmlns.com/foaf/0.1/topic_interest SAXS Cryo-TEM
http://xmlns.com/foaf/0.1/topic_interest Blood-brain barrier
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/phys
http://xmlns.com/foaf/0.1/topic_interest Neuroinflammation
http://xmlns.com/foaf/0.1/topic_interest Nanomedicine for growth factor delivery
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.neu.nb
http://xmlns.com/foaf/0.1/topic_interest ROS
http://xmlns.com/foaf/0.1/topic_interest Liposomes
http://xmlns.com/foaf/0.1/topic_interest Anti-inflammatory and anti-apoptotic agents
http://xmlns.com/foaf/0.1/topic_interest Curcumin amphiphilic nanoparticles self-assembled nanoparticles solid lipid nanoparticles liposomes liquid crystalline carriers nanomedicine drug delivery neurodegenerative diseases Alzheimer's disease Parkinson's disease Huntington disease amyotrophic lateral sclerosis oxidative stress neuroprotection antioxidant blood-brain barrier SHSY-5Y cells
http://xmlns.com/foaf/0.1/topic_interest Neurodegeneration
http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://xmlns.com/foaf/0.1/Person
http://xmlns.com/foaf/0.1/topic_interest Neuroprotective assemblies
http://xmlns.com/foaf/0.1/topic_interest Alzheimer's disease
http://xmlns.com/foaf/0.1/topic_interest Liquid crystalline nanocarriers
http://xmlns.com/foaf/0.1/topic_interest Tunicamycin
http://xmlns.com/foaf/0.1/topic_interest Neurological long COVID-19
http://xmlns.com/foaf/0.1/topic_interest Liquid crystalline carriers
http://xmlns.com/foaf/0.1/topic_interest Curcumin
http://xmlns.com/foaf/0.1/topic_interest Biotherapeutics
http://xmlns.com/foaf/0.1/topic_interest Amyotrophic lateral sclerosis
http://xmlns.com/foaf/0.1/topic_interest Nanotherapy
http://xmlns.com/foaf/0.1/topic_interest Spongosome
http://xmlns.com/foaf/0.1/topic_interest Neuroprotection
http://xmlns.com/foaf/0.1/topic_interest Neurological long COVID
http://xmlns.com/foaf/0.1/topic_interest Cubosome
http://xmlns.com/foaf/0.1/topic_interest Lipid nanoparticles
http://xmlns.com/foaf/0.1/topic_interest Nanofibers
http://xmlns.com/foaf/0.1/firstName Angelina
http://xmlns.com/foaf/0.1/topic_interest Lipid nanocarriers
http://xmlns.com/foaf/0.1/topic_interest Parkinson's disease
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/sdv.bbm.bc
http://xmlns.com/foaf/0.1/familyName Angelova
http://xmlns.com/foaf/0.1/topic_interest Neurodegenerative diseases
http://www.w3.org/2002/07/owl#sameAs 0000-0002-0285-0637
http://xmlns.com/foaf/0.1/topic_interest Cell-penetrating peptide CPP
http://xmlns.com/foaf/0.1/topic_interest Neuroinvasive coronavirus infection
http://xmlns.com/foaf/0.1/topic_interest Drug delivery
http://xmlns.com/foaf/0.1/topic_interest Solid lipid nanoparticles
http://xmlns.com/foaf/0.1/topic_interest Lipid liquid crystalline nanoparticles
http://xmlns.com/foaf/0.1/topic_interest Nanocarriers
http://xmlns.com/foaf/0.1/interest https://data.archives-ouvertes.fr/subject/chim.mate
http://xmlns.com/foaf/0.1/topic_interest Oxidative stress
http://www.openarchives.org/ore/terms/isAggregatedBy https://data.archives-ouvertes.fr/author/angelina-angelova

Télécharger au format